• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估细胞外信号调节激酶 1 和 2 在容量超负荷诱导的心脏重构中的作用。

Assessing the role of extracellular signal-regulated kinases 1 and 2 in volume overload-induced cardiac remodelling.

机构信息

Department of Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany.

King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, UK.

出版信息

ESC Heart Fail. 2019 Oct;6(5):1015-1026. doi: 10.1002/ehf2.12497. Epub 2019 Jul 19.

DOI:10.1002/ehf2.12497
PMID:31322843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6816056/
Abstract

AIMS

Volume overload (VO) and pressure overload (PO) induce differential cardiac remodelling responses including distinct signalling pathways. Extracellular signal-regulated kinases 1 and 2 (ERK1/2), key signalling components in the mitogen-activated protein kinase (MAPK) pathways, modulate cardiac remodelling during pressure overload (PO). This study aimed to assess their role in VO-induced cardiac remodelling as this was unknown.

METHODS AND RESULTS

Aortocaval fistula (Shunt) surgery was performed in mice to induce cardiac VO. Two weeks of Shunt caused a significant reduction of cardiac ERK1/2 activation in wild type (WT) mice as indicated by decreased phosphorylation of the TEY (Thr-Glu-Tyr) motif (-28% as compared with Sham controls, P < 0.05). Phosphorylation of other MAPKs was unaffected. For further assessment, transgenic mice with cardiomyocyte-specific ERK2 overexpression (ERK2tg) were studied. At baseline, cardiac ERK1/2 phosphorylation in ERK2tg mice remained unchanged compared with WT littermates, and no overt cardiac phenotype was observed; however, cardiac expression of the atrial natriuretic peptide was increased on messenger RNA (3.6-fold, P < 0.05) and protein level (3.1-fold, P < 0.05). Following Shunt, left ventricular dilation and hypertrophy were similar in ERK2tg mice and WT littermates. Left ventricular function was maintained, and changes in gene expression indicated reactivation of the foetal gene program in both genotypes. No differences in cardiac fibrosis and kinase activation was found amongst all experimental groups, whereas apoptosis was similarly increased through Shunt in ERK2tg and WT mice.

CONCLUSIONS

VO-induced eccentric hypertrophy is associated with reduced cardiac ERK1/2 activation in vivo. Cardiomyocyte-specific overexpression of ERK2, however, does not alter cardiac remodelling during VO. Future studies need to define the pathophysiological relevance of decreased ERK1/2 signalling during VO.

摘要

目的

容量超负荷(VO)和压力超负荷(PO)引起不同的心脏重塑反应,包括不同的信号通路。细胞外信号调节激酶 1 和 2(ERK1/2)是丝裂原激活蛋白激酶(MAPK)途径中的关键信号成分,调节压力超负荷(PO)时的心脏重塑。本研究旨在评估它们在 VO 诱导的心脏重塑中的作用,因为这一点尚不清楚。

方法和结果

在小鼠中进行腹主动脉-腔静脉瘘(Shunt)手术以诱导心脏 VO。两周的 Shunt 导致野生型(WT)小鼠心脏 ERK1/2 激活显著减少,表现为 TEY(Thr-Glu-Tyr)基序磷酸化减少(与 Sham 对照组相比减少 28%,P < 0.05)。其他 MAPKs 的磷酸化不受影响。为了进一步评估,研究了心肌细胞特异性 ERK2 过表达(ERK2tg)的转基因小鼠。在基线时,与 WT 同窝仔相比,ERK2tg 小鼠的心脏 ERK1/2 磷酸化保持不变,并且没有明显的心脏表型观察到;然而,心房利钠肽的信使 RNA(3.6 倍,P < 0.05)和蛋白水平(3.1 倍,P < 0.05)表达增加。在 Shunt 后,ERK2tg 小鼠和 WT 同窝仔的左心室扩张和肥大相似。左心室功能得以维持,基因表达的变化表明两种基因型中胎儿基因程序的重新激活。在所有实验组中,心脏纤维化和激酶激活没有差异,而通过 Shunt,ERK2tg 和 WT 小鼠的凋亡同样增加。

结论

VO 诱导的偏心性肥大与体内心脏 ERK1/2 激活减少有关。然而,心肌细胞特异性过表达 ERK2 不会改变 VO 期间的心脏重塑。未来的研究需要确定 VO 期间 ERK1/2 信号减少的病理生理相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/124816ad6930/EHF2-6-1015-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/4a498caf2517/EHF2-6-1015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/1cf461f21265/EHF2-6-1015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/1062a49e265b/EHF2-6-1015-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/a60e36be8532/EHF2-6-1015-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/ca276a5dc3a8/EHF2-6-1015-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/124816ad6930/EHF2-6-1015-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/4a498caf2517/EHF2-6-1015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/1cf461f21265/EHF2-6-1015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/1062a49e265b/EHF2-6-1015-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/a60e36be8532/EHF2-6-1015-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/ca276a5dc3a8/EHF2-6-1015-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d21/6816056/124816ad6930/EHF2-6-1015-g006.jpg

相似文献

1
Assessing the role of extracellular signal-regulated kinases 1 and 2 in volume overload-induced cardiac remodelling.评估细胞外信号调节激酶 1 和 2 在容量超负荷诱导的心脏重构中的作用。
ESC Heart Fail. 2019 Oct;6(5):1015-1026. doi: 10.1002/ehf2.12497. Epub 2019 Jul 19.
2
NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload.NADPH 氧化酶-4 促进了对容量超负荷的偏心性心肌肥厚。
Cardiovasc Res. 2021 Jan 1;117(1):178-187. doi: 10.1093/cvr/cvz331.
3
IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.IQGAP1 在心脏中调节 ERK1/2 和 AKT 信号转导,并在压力超负荷时维持功能重塑。
Cardiovasc Res. 2011 Aug 1;91(3):456-64. doi: 10.1093/cvr/cvr103. Epub 2011 Apr 14.
4
Hemodynamic stress-induced cardiac remodelling is not modulated by ablation of phosphodiesterase 4D interacting protein.血流动力性应激诱导的心脏重构不受磷酸二酯酶 4D 相互作用蛋白消融的调节。
J Cell Mol Med. 2022 Aug;26(16):4440-4452. doi: 10.1111/jcmm.17468. Epub 2022 Jul 20.
5
Molecular and structural transition mechanisms in long-term volume overload.长期容量超负荷时的分子与结构转变机制
Eur J Heart Fail. 2016 Apr;18(4):362-71. doi: 10.1002/ejhf.465. Epub 2015 Dec 23.
6
Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.丝裂原活化蛋白激酶(p38和c-Jun氨基末端激酶)在心脏容量和压力超负荷肥大过程中受到不同程度的调节。
Cell Biochem Biophys. 2005;43(1):61-76. doi: 10.1385/CBB:43:1:061.
7
Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth.细胞外信号调节激酶 1 和 2 调节偏心性和同心性心脏生长之间的平衡。
Circ Res. 2011 Jan 21;108(2):176-83. doi: 10.1161/CIRCRESAHA.110.231514. Epub 2010 Dec 2.
8
Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.在压力超负荷引起的心肌肥厚向心力衰竭的转变过程中,存活信号通路的下调和细胞凋亡的增加。
Clin Exp Pharmacol Physiol. 2009 Nov;36(11):1054-61. doi: 10.1111/j.1440-1681.2009.05243.x. Epub 2009 Jun 29.
9
USP20 deletion promotes eccentric cardiac remodeling in response to pressure overload and increases mortality.USP20 缺失促进了压力超负荷反应中心肌的重塑,并增加了死亡率。
Am J Physiol Heart Circ Physiol. 2024 Nov 1;327(5):H1257-H1271. doi: 10.1152/ajpheart.00329.2024. Epub 2024 Oct 4.
10
Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.心肌细胞中ERK2的靶向缺失可减弱肥厚反应,但会引发病理性应激诱导的心脏功能障碍。
J Mol Cell Cardiol. 2014 Jul;72(100):104-16. doi: 10.1016/j.yjmcc.2014.03.002. Epub 2014 Mar 12.

引用本文的文献

1
Ginsenoside Rg1 treats chronic heart failure by downregulating ERK1/2 protein phosphorylation.人参皂苷 Rg1 通过下调 ERK1/2 蛋白磷酸化治疗慢性心力衰竭。
In Vitro Cell Dev Biol Anim. 2024 Oct;60(9):1085-1098. doi: 10.1007/s11626-024-00960-w. Epub 2024 Sep 9.
2
Different activation of MAPKs and Akt/GSK3β after preload vs. afterload elevation.预负荷和后负荷增加后 MAPKs 和 Akt/GSK3β 的不同激活。
ESC Heart Fail. 2022 Jun;9(3):1823-1831. doi: 10.1002/ehf2.13877. Epub 2022 Mar 21.
3
Haematopoietic and cardiac GPR55 synchronize post-myocardial infarction remodelling.

本文引用的文献

1
p38-MAP Kinase Negatively Regulates the Slow Force Response to Stretch in Rat Myocardium through the Up-Regulation of Dual Specificity Phosphatase 6 (DUSP6).p38丝裂原活化蛋白激酶通过上调双特异性磷酸酶6(DUSP6)负向调节大鼠心肌对拉伸的慢力反应。
Cell Physiol Biochem. 2019;52(2):172-185. doi: 10.33594/000000012. Epub 2019 Feb 28.
2
Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.压力与容量超负荷所致的心脏肥厚及信号通路的差异。
Am J Physiol Heart Circ Physiol. 2018 Mar 1;314(3):H552-H562. doi: 10.1152/ajpheart.00212.2017. Epub 2017 Dec 1.
3
Echocardiographic evaluation of diastolic function in mouse models of heart disease.
造血和心脏 GPR55 同步心肌梗死后重塑。
Sci Rep. 2021 Jul 13;11(1):14385. doi: 10.1038/s41598-021-93755-y.
4
Role of extracellular signal-regulated kinase 1/2 signaling underlying cardiac hypertrophy.细胞外信号调节激酶1/2信号传导在心脏肥大中的作用。
Cardiol J. 2021;28(3):473-482. doi: 10.5603/CJ.a2020.0061. Epub 2020 Apr 24.
超声心动图评价心脏病小鼠模型的舒张功能。
J Mol Cell Cardiol. 2018 Jan;114:20-28. doi: 10.1016/j.yjmcc.2017.10.006. Epub 2017 Oct 19.
4
Molecular and structural transition mechanisms in long-term volume overload.长期容量超负荷时的分子与结构转变机制
Eur J Heart Fail. 2016 Apr;18(4):362-71. doi: 10.1002/ejhf.465. Epub 2015 Dec 23.
5
The Akt-mTOR axis is a pivotal regulator of eccentric hypertrophy during volume overload.Akt-mTOR轴是容量超负荷期间离心性肥大的关键调节因子。
Sci Rep. 2015 Oct 30;5:15881. doi: 10.1038/srep15881.
6
Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophy.细胞外信号调节激酶1/2作为心脏肥大的调节因子。
Front Pharmacol. 2015 Jul 24;6:149. doi: 10.3389/fphar.2015.00149. eCollection 2015.
7
Elucidating ERK2 function in the heart.阐明心脏中ERK2的功能。
J Mol Cell Cardiol. 2014 Jul;72:336-8. doi: 10.1016/j.yjmcc.2014.04.009. Epub 2014 Apr 24.
8
Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.心肌细胞中ERK2的靶向缺失可减弱肥厚反应,但会引发病理性应激诱导的心脏功能障碍。
J Mol Cell Cardiol. 2014 Jul;72(100):104-16. doi: 10.1016/j.yjmcc.2014.03.002. Epub 2014 Mar 12.
9
Atrial natriuretic peptide affects cardiac remodeling, function, heart failure, and survival in a mouse model of dilated cardiomyopathy.心房利钠肽影响扩张型心肌病小鼠模型的心脏重构、功能、心力衰竭和生存。
Hypertension. 2014 Mar;63(3):514-9. doi: 10.1161/HYPERTENSIONAHA.113.02164. Epub 2013 Dec 30.
10
Pathological ventricular remodeling: therapies: part 2 of 2.病理性心室重塑:治疗方法:第2部分,共2部分
Circulation. 2013 Aug 27;128(9):1021-30. doi: 10.1161/CIRCULATIONAHA.113.001879.